SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Weight Watchers (WW)
Weight Watchers (WW)
Newsletters
Exclusive: The founders of SoulCycle built a startup for relationships, then pivoted to GLP-1 support groups. Now its assets are being acquired by WeightWatchers
By
Emma Hinchliffe
August 7, 2025
Finance
WeightWatchers files for bankruptcy as it struggles for a place in a weight loss world dominated by Ozempic and Wegovy
By
The Associated Press
May 7, 2025
Health
Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
By
Lindsey Leake
February 3, 2025
Retail
Secondhand luxury fashion thrives as Ozempic users purge their closets
By
Sasha Rogelberg
August 29, 2024
Health
Exclusive: The COO of Hims & Hers was the third person to try their new weight loss drugs—and she’s ready to share her story
By
Alexa Mikhail
August 14, 2024
Newsletters
CEO Sima Sistani didn’t think running WeightWatchers would be this hard
By
Emma Hinchliffe
and
Joey Abrams
June 11, 2024
Retail
Nestlé’s new foods are getting Ozempified, with slashed portions priced specifically for those on weight-loss drugs
By
Sasha Rogelberg
May 21, 2024
Finance
WeightWatchers, reeling from collapsing stock and Oprah’s departure in the age of Ozempic, vows to ‘prove the naysayers wrong’ and turn its fortunes around
By
Amanda Gerut
March 14, 2024
Leadership
Oprah to leave WeightWatchers board, donating her stake over ‘perceived conflict of interest around her taking weight loss medications’
By
Amanda Gerut
February 29, 2024
Health
WeightWatchers’ worst month ever—a stark reversal of 2023—wipes out obesity-drug gains
By
Katrina Compoli
and
Bloomberg
February 2, 2024
Success
Florine Mark, Weight Watchers franchisee who became Michigan business icon, dies at 90
By
The Associated Press
October 13, 2023
Magazine
Novo Nordisk developed Ozempic and started a weight-loss revolution. Its next moonshot is eliminating obesity altogether
By
Vivienne Walt
July 31, 2023
Features
The end of dieting: WeightWatchers and Noom are now pushing Ozempic-like miracle drugs over willpower
By
Maria Aspan
July 24, 2023
Health
WeightWatchers makes a play for the prescription drug market by buying a telehealth company with access to Ozempic and Wegovy
By
Michelle Chapman
and
The Associated Press
March 7, 2023
Newsletters
After founding Houseparty, WeightWatchers CEO Sima Sistani is turning the 60-year-old diet platform into a digital community
By
Emma Hinchliffe
November 21, 2022
Most Popular
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
By
Jason Ma
Success
This Stanford computer science professor went to written exams 2 years ago because of AI. He says his students insisted...
By
Nick Lichtenberg
North America
Farmer says 'we're in a very dire situation' ahead of harvest—with zero soybean orders from China, historically the...
By
Dave Smith